Doximity has acquired Pathway Medical, an AI-based clinical reference tool, for $63 million, significantly enhancing its AI capabilities. As a leading digital platform for U.S. healthcare professionals, Doximity provides access to a robust medical network and essential digital health tools, including telehealth services via its mobile app. The company has received the Best in KLAS award for video conferencing platforms for two consecutive years, showcasing its high customer satisfaction scores.
Pathway Medical offers an AI-driven platform that delivers curated information to healthcare providers at the point of care, leveraging a vast dataset including clinical guidelines and studies across multiple specialties. With this acquisition, Doximity aims to elevate its clinical reference capabilities, making Pathway’s subscription-based service available for free to its members. Furthermore, Doximity already utilizes AI tools like Doximity GPT for clinical documentation and decision support, demonstrating its commitment to advancing AI in healthcare, while acknowledging its risks.
Source link
